Suchergebnisse

Alphabet’s GOOGL first-quarter 2026 results, scheduled to be released on April 29, are expected to have benefited from solid momentum in Search and Cloud businesses. The momentum in Search is

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Vertex Pharmaceuticals VRTX is scheduled to report its first-quarter 2026 results on May 4, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at

Amneal Pharmaceuticals AMRX is coming off a strong 12-month run, but the stock’s valuation still screens as discounted versus key benchmarks. That combination can keep investor attention high

Amneal Pharmaceuticals AMRX is leaning into a playbook that can work in multiple market backdrops. The company is pairing steady demand in generics with higher-value opportunities in complex

The first-quarter reporting season for the Auto-Tires-Trucks space has kicked off, with a mixed start. So far, four S&P 500 players—Tesla, Genuine Parts, General Motors and PACCAR—have announced

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of

Amgen AMGN will report first-quarter 2026 results on April 30 after market close. In the last reported quarter, the company's earnings beat expectations by 11.13%. The Zacks Consensus Estimate for

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Canadian Pacific Kansas City CP is scheduled to report first-quarter 2026 results on April 29, after the market close.

The Zacks Consensus Estimate for CP’s first-quarter 2026 earnings has been

Amneal Pharmaceuticals AMRX is leaning into complex products and biosimilars to drive steadier growth. The 2026 setup centers on an elevated launch cadence in Affordable Medicines and expanding

Investors can improve results by taking a more active approach to stock selection by focusing on potential breakout opportunities within clearly defined price ranges. Under this strategy, a stock is

Veralto (VLTO) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.95 per share a year ago. These figures

Waste Management (WM) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.67 per share a year ago. These

Welltower (WELL) came out with quarterly funds from operations (FFO) of $1.47 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to FFO of $1.2 per share a year ago

Webster Financial (WBS) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.3 per share a year ago. These

Stag Industrial (STAG) came out with quarterly funds from operations (FFO) of $0.65 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.61 per share a year ago. These